XBIT NASDAQ
XBiotech Inc.
1W: +0.9%
1M: +0.0%
3M: -9.1%
YTD: -8.0%
1Y: -17.1%
3Y: -45.5%
5Y: -84.7%
$2.19
-0.01 (-0.45%)
Weekly Expected Move ±1.9%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (24h)
1
Hourly Sentiment (24h)
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (9)
XBiotech (NASDAQ:XBIT) Share Price Breaks Below 50-Day Moving Average – Time to Sell?
XBiotech (NASDAQ:XBIT) Stock Price Crosses Below 50-Day Moving Average – What’s Next?
BlackRock Inc. Makes New $739,000 Investment in XBiotech Inc. $XBIT
XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis
XBiotech startet klinische Phase-II-Studie zur Bewertung von Vilamakitug bei der Behandlung der aktiven axialen Spondyloarthritis
XBiotech lance un essai clinique de phase II visant à évaluer le vilamakitug dans le traitement de la spondylarthrite axiale active
XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis
Short Interest in XBiotech Inc. (NASDAQ:XBIT) Expands By 21.3%
XBiotech (NASDAQ:XBIT) Share Price Crosses Above Fifty Day Moving Average – Should You Sell?